Jonathan C. Roberts - 01 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP & Chief Operating Officer
Signature
Jonathan C. Roberts
Issuer symbol
CVS
Transactions as of
01 Apr 2022
Transactions value $
$2,627,026
Form type
4
Filing time
05 Apr 2022, 17:43:33 UTC
Previous filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock 426K 01 Apr 2022 Direct
holding CVS Common Stock 38.2K 01 Apr 2022 By GRAT
holding CVS Common Stock (restricted) 12.8K 01 Apr 2022 Direct
holding CVS ESOP Common Stock 6.16K 01 Apr 2022 By ESOP
holding CVS Stock Unit 341K 01 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $2.63M +26K $101.09 26K 01 Apr 2022 Common Stock 26K $101.09 Direct F1
holding CVS Phantom Stock Credits 1.42K 01 Apr 2022 Common Stock 1.42K $1.00 Direct F2
holding CVS Stock Option 161K 01 Apr 2022 Common Stock 161K $104.82 Direct F3
holding CVS Stock Option 200K 01 Apr 2022 Common Stock 200K $78.05 Direct F4
holding CVS Stock Option 248K 01 Apr 2022 Common Stock 248K $62.21 Direct F5
holding CVS Stock Option 303K 01 Apr 2022 Common Stock 303K $54.19 Direct F6
holding CVS Stock Option 239K 01 Apr 2022 Common Stock 239K $58.34 Direct F7, F8
holding CVS Stock Option 173K 01 Apr 2022 Common Stock 173K $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option becomes exercisable in four equal installments, commencing 4/1/2023.
F2 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Options became exercisable in four equal installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal installments, commencing 4/1/2022.